Clinical Trial Update: Conversion From Unresectable To Resectable Metastatic Colorectal Cancer. [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is exploring conversion from unresectable to resectable metastatic colorectal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University of Saskatchewan | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING